Margetuximab Antibody
Margetuximab (MGAH-22) is a second-generation, Fc-engineered monoclonal antibody targeting HER2, used in research for metastatic HER2-positive breast cancer. It is applied in both in vitro cell studies and in vivo tumor models to investigate therapeutic mechanisms and serves as a component in the development of targeted nanomedicines.
Product Specifications
Product Name Alternative
MGAH22, MGAH-22
Target
HER, EGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cardiovascular Research, Signal Transduction
Concentration
14.34 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.86 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
